Relevance of non-albumin colloids in intensive care medicine.
about
Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.Effect of 6% hydroxyethyl starch-450 and low molecular weight dextran on blood sugar levels during surgery under subarachnoid block: A prospective randomised studyHydroxyeyhyl starch: Controversies revisitedFluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock.Are all colloids same? How to select the right colloid?Anesthesia for bone replacement surgery.Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.Pros and cons of tetrastarch solution for critically ill patientsControversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care.Intravenous Fluid Therapy in Traumatic Brain Injury and Decompressive Craniectomy.The choice of the intravenous fluid influences the tolerance of acute normovolemic anemia in anesthetized domestic pigsFast-track Orthognathic Surgery: An Evidence-based Review.Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery.Effect of gelatin-polysuccinat on cerebral oxygenation and microcirculation in a porcine haemorrhagic shock model.[Volume replacement in intensive care medicine].Effects of hematocrit and red blood cell-independent viscosity on canine thromboelastographic tracings.Analysis of gelatin plasma substitutes in blood based on detection of hydroxyproline derivatives.
P2860
Q33919086-AFD192CD-7A17-488A-8136-D3D12D1E6F45Q34349624-F6D50519-0277-4AC8-A6CA-85A364351E04Q34527810-8F3C6E24-8C3C-4F5D-A084-516CCAFA2E9FQ36093621-3F75005E-3975-4323-8785-1E5646B5A1D6Q37773793-57E46DD3-C1CC-4B9A-944D-8FBBC3DDF128Q38007443-3E026851-0832-440C-8AF1-D070152F3FD1Q38083557-EF3F0CF3-96AB-4DD0-AAB9-2051C3BB598DQ38292754-897DAE24-6CAA-4818-AFEE-8B547FD2148EQ38345631-0424B7EF-7232-4FCD-8FF2-4D55A0FECBB0Q38679351-731AF2F6-D38E-461E-A371-389762C8FFB5Q42121781-506F824E-C11B-4A0C-9031-AC50160F6F48Q47135276-D1FE82C9-3E54-4448-85CD-EE81E683785CQ47177602-2B908D2E-F5D8-48E1-A44E-E2A553B7CA2FQ50094046-BBC12E10-A5FF-455A-AAE1-FA37FFBE1F1EQ50162593-E8440470-8613-40DB-8DB9-E0A69E94A81EQ50487834-678ED8B0-EF01-4DA0-A8AD-806B47FE8C65Q51684806-03EE8CD5-0BDA-4F40-970F-E870BE1B7434
P2860
Relevance of non-albumin colloids in intensive care medicine.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Relevance of non-albumin colloids in intensive care medicine.
@ast
Relevance of non-albumin colloids in intensive care medicine.
@en
type
label
Relevance of non-albumin colloids in intensive care medicine.
@ast
Relevance of non-albumin colloids in intensive care medicine.
@en
prefLabel
Relevance of non-albumin colloids in intensive care medicine.
@ast
Relevance of non-albumin colloids in intensive care medicine.
@en
P2093
P1476
Relevance of non-albumin colloids in intensive care medicine.
@en
P2093
Christian Ertmer
Martin Westphal
Sebastian Rehberg
P304
P356
10.1016/J.BPA.2008.11.001
P577
2009-06-01T00:00:00Z